Target intelligence / Profile preview

Cutaneous proteins

Molecular classification
Structural protein, Enzyme, Receptor, Transcription factor, Other
01

Overview

Cutaneous proteins is a collective term referring to the diverse set of proteins found within the layers of the skin, including the epidermis, dermis, and hypodermis. This group includes essential structural proteins such as keratins, which provide the primary mechanical barrier in the epidermis, and collagen and elastin, which maintain the tensile strength and elasticity of the dermis (UniProt, 2024; PubMed, 2023). Beyond structural roles, cutaneous proteins encompass functional entities such as matrix metalloproteinases, heat shock proteins (e.g., HSP70), and various signaling molecules that regulate skin immunity and repair (Slominski et al., 2000). These proteins are critical in the pathogenesis of numerous conditions; for instance, atopic dermatitis is frequently linked to filaggrin deficiency, while psoriasis is characterized by aberrant keratinocyte protein expression (NIH, 2024). Additionally, the degradation and glycation of dermal proteins like collagen are primary drivers of intrinsic and extrinsic skin aging (MDPI, 2023). In pharmacology, cutaneous proteins serve as therapeutic targets for agents like retinoids, which modulate the synthesis of keratins and collagen, and keratolytic agents, which target the structural integrity of the stratum corneum. They also act as unintentional targets for chemical haptens, which bind to these proteins to form immunogenic adducts that trigger allergic contact dermatitis (Brites et al., 2022). Because the term refers to a vast collection of distinct molecular entities rather than a single molecule, it is classified as a broad biological category rather than a specific therapeutic target.

Other names
Skin proteinsEpidermal proteinsDermal proteinsIntegumentary proteins
02

Mechanism of action

Modulation of protein expression through nuclear receptor binding, enzymatic degradation of extracellular matrix components, or chemical modification of structural residues.

03

Biological functions

Structural integrityBarrier functionImmune responseSignal transductionWound healingUV protection
04

Disease associations

InflammationCancerAgingInfectionOther
05

Safety considerations

Skin irritationAllergic contact dermatitisPhotosensitivityImpaired wound healingSystemic absorption toxicity
06

Interacting drugs

Tretinoin

6 more in the full profile.

07

Biomarkers

FilaggrinKeratin 1Keratin 10Collagen type IElastinTrans-epidermal water loss (TEWL)

Beyond the preview

Go deeper on Cutaneous proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutaneous proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call